Exenatide and glucagon co-infusion increases myocardial glucose uptake and improves markers of diastolic dysfunction in adults with type 2 diabetes.
Goodman J, Schain M, Di Stefano G, Lupson V, Horn T, Hill M, Manavaki R, Fryer TD, Bumanlag-Amis E, Jalaludeen N, Jermutus L, Johansson E, Heurling K, Haraldsson H, Evans M, Cheriyan J, Johansson L, Ambery P, Wilkinson IB.
Goodman J, et al. Among authors: horn t.
Sci Rep. 2025 Jul 1;15(1):21404. doi: 10.1038/s41598-025-04559-3.
Sci Rep. 2025.
PMID: 40593987
Free PMC article.
Clinical Trial.